Skip to main content

Table 2 Changes in disability (HAQ scores) by EULAR response mean scores (95 % confidence intervals)

From: Optimal responses in disease activity scores to treatment in rheumatoid arthritis: Is a DAS28 reduction of >1.2 sufficient?

 

None

Moderate

Good

Difference moderate and good

CARDERA

0.10 (–0.01, 0.21)

–0.39 (–0.48, –0.30)

–0.88 (–1.02, –0.73)

–0.49 (–0.66, –0.32)

TACIT

–0.04 (–0.15, 0.08)

–0.33 (-0.44, -0.22)

–0.64 (–0.77, –0.51)

–0.30 (–0.47, –0.13)

  1. EULAR European League Against Rheumatism, CARDERA cost-effectiveness of treatment strategies using combination of disease-modifying anti-rheumatic drugs and glucocorticoids in early rheumatoid arthritis, TACIT tumour necrosis factor inhibitors against combination intensive therapy